Finance

Lists
532321:BOM
Zydus Lifesciences Ltd
₹1,190.10
-1.89%
(-22.95) 1D
Nov 11, 3:30:05 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 532321...
Open
₹1,216.35
High
₹1,222.90
Low
₹1,190.10
Mkt. cap
1.20T
Avg. vol.
119.02K
Volume
544.07K
52-wk high
₹1,266.15
52-wk low
₹835.85
No. of employees
30K
Open
₹1,216.35
High
₹1,222.90
Low
₹1,190.10
Mkt. cap
1.20T
Avg. vol.
119.02K
Volume
544.07K
52-wk high
₹1,266.15
52-wk low
₹835.85
No. of employees
30K
News stories
From web sources and news partners
Profile
Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, is an Indian multinational pharmaceutical company, headquartered in Ahmedabad, India. Primarily engaged in the manufacturing of generic drugs, the company ranked 100th in the Fortune India 500 list in 2020. Wikipedia
About Zydus Lifesciences Ltd
CEO-
Employees30K
Founded1952
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitezyduslife.com
Last report
Nov 4, 2026
Fiscal period
Q2 2027
₹9.28 / ₹8.78
+5.69%beat
Revenue / Est. (INR)
79.10B / 75.88B
+4.23%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
68.64B
75.87B
80.17B
79.10B
Cost of goods sold
18.36B
22.07B
22.40B
21.54B
Cost of revenue
18.36B
22.07B
22.40B
21.54B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11.40B
32.92B
13.68B
13.57B
Operating expense
37.36B
39.40B
44.59B
46.02B
Total operating expenses
55.72B
61.48B
66.99B
67.56B
Operating income
12.92B
14.39B
13.18B
11.53B
Other non operating income
1.11B
-3.70B
1.06B
1.30B
EBT including unusual items
14.11B
16.59B
13.44B
12.62B
EBT excluding unusual items
14.96B
20.88B
13.63B
12.60B
Income tax expense
3.88B
3.18B
3.54B
3.34B
Effective tax rate
27.52%
19.19%
26.35%
26.47%
Other operating expenses
22.36B
1.28B
25.36B
26.40B
Net income
10.42B
12.72B
9.40B
9.26B
Net profit margin
15.18%
16.77%
11.72%
11.70%
Earnings per share
10.96
15.84
9.48
9.28
Interest and investment income
-
4.24B
-
-
Interest expense
-1.30B
-491.00M
-1.56B
-1.87B
Net interest expenses
-1.30B
3.75B
-1.56B
-1.87B
Depreciation and amortization charges
3.60B
5.08B
5.55B
6.04B
EBITDA
15.10B
17.74B
16.53B
17.21B
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps